Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Larson

Showing results (141-150 of 300) with videos related to

Pageof 30
Sort By:
Diseases of the Colon and Rectum|March 20, 2012
FDG-PET assessment of rectal cancer response to neoadjuvant chemoradiotherapy is not associated with long-term prognosis: a prospective evaluationJeannine A Ruby, Tobias Leibold, Timothy J Akhurst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Integrated positron emission tomography/computed tomography may render bone scintigraphy unnecessary to investigate suspected metastatic breast cancerPatrick G Morris, Colleen Lynch, John N Feeney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2010
Prognostic value of baseline [18F] fluorodeoxyglucose positron emission tomography and 99mTc-MDP bone scan in progressing metastatic prostate cancerGustavo S P Meirelles, Heiko Schöder, Gregory C Ravizzini, et al.
Molecular Imaging and Biology|June 1, 2013
Evaluation of arginine deiminase treatment in melanoma xenografts using (18)F-FLT PETLars Stelter, Simon Fuchs, Achim A Jungbluth, et al.
EJNMMI Research|March 11, 2016
Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamideAseem Anand, Michael J Morris, Steven M Larson, et al.
Nuclear Medicine and Biology|March 22, 2008
Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003Peter M Smith-Jones, Neeta Pandit-Taskar, Wei Cao, et al.
Hepatobiliary Surgery and Nutrition|August 26, 2022
Prospective evaluation of <sup>18</sup>F-FDG positron emission tomography in the preoperative staging of patients with hepatic colorectal metastasesTim Akhurst, Mithat Gönen, Raymond E Baser, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 15, 2010
Imaging expression of the human somatostatin receptor subtype-2 reporter gene with 68Ga-DOTATOCHanwen Zhang, Maxim A Moroz, Inna Serganova, et al.
Medical Physics|March 29, 2007
Biomedical imaging research opportunities workshop IV: a white paperWilliam R Hendee, Filip Banovac, Paul L Carson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 22, 2002
Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancerRodolfo Nuñez, Homer A Macapinlac, Henry W D Yeung, et al.
Pageof 30

Showing results (141-150 of 300) with videos related to

Sort By:
Pageof 30
Diseases of the Colon and Rectum|March 20, 2012
FDG-PET assessment of rectal cancer response to neoadjuvant chemoradiotherapy is not associated with long-term prognosis: a prospective evaluationJeannine A Ruby, Tobias Leibold, Timothy J Akhurst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Integrated positron emission tomography/computed tomography may render bone scintigraphy unnecessary to investigate suspected metastatic breast cancerPatrick G Morris, Colleen Lynch, John N Feeney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2010
Prognostic value of baseline [18F] fluorodeoxyglucose positron emission tomography and 99mTc-MDP bone scan in progressing metastatic prostate cancerGustavo S P Meirelles, Heiko Schöder, Gregory C Ravizzini, et al.
Molecular Imaging and Biology|June 1, 2013
Evaluation of arginine deiminase treatment in melanoma xenografts using (18)F-FLT PETLars Stelter, Simon Fuchs, Achim A Jungbluth, et al.
EJNMMI Research|March 11, 2016
Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamideAseem Anand, Michael J Morris, Steven M Larson, et al.
Nuclear Medicine and Biology|March 22, 2008
Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003Peter M Smith-Jones, Neeta Pandit-Taskar, Wei Cao, et al.
Hepatobiliary Surgery and Nutrition|August 26, 2022
Prospective evaluation of <sup>18</sup>F-FDG positron emission tomography in the preoperative staging of patients with hepatic colorectal metastasesTim Akhurst, Mithat Gönen, Raymond E Baser, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 15, 2010
Imaging expression of the human somatostatin receptor subtype-2 reporter gene with 68Ga-DOTATOCHanwen Zhang, Maxim A Moroz, Inna Serganova, et al.
Medical Physics|March 29, 2007
Biomedical imaging research opportunities workshop IV: a white paperWilliam R Hendee, Filip Banovac, Paul L Carson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 22, 2002
Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancerRodolfo Nuñez, Homer A Macapinlac, Henry W D Yeung, et al.
Pageof 30